Welcoming Dr. Neil Horowitz as Executive Vice Chair and Vice Chair of Gynecology

We are honored to share that Neil Horowitz, MD, joined the BIDMC Department of Obstetrics and Gynecology on October 15 as Executive Vice Chair and Vice Chair of Gynecology.

Dr. Horowitz comes to us from Mass General Brigham, where he served as Division Chief of the combined MGB Division of Gynecologic Oncology. Dr. Horowitz brings a track record of building programs, growing research portfolios, and mentoring the next generation of clinicians. We are confident his leadership will further strengthen our shared commitment to delivering exceptional, compassionate care for every patient we serve.

Dr. Horowitz earned his medical degree from Duke University School of Medicine and completed his residency in Obstetrics and Gynecology at the University of Washington Medical Center in Seattle. He completed a Galloway Fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center during residency, followed by a Gynecologic Oncology fellowship at Barnes-Jewish Hospital in St. Louis. He has spent the majority of his career at Mass General Brigham, where he built a comprehensive Gynecologic Oncology practice at Brigham and Women’s Hospital and Dana-Farber Cancer Institute and served as Program Director of Gynecologic Oncology for the MGB Cancer Institute.

Dr. Horowitz has authored more than 125 peer-reviewed publications throughout his career. Through his research, he addresses the surgical and medical management of ovarian cancer and the treatment of vulvar cancer, including work that helped establish cisplatin, gemcitabine, and IMRT as a new standard of care for locally advanced vulvar cancer. His primary academic focus has been gestational trophoblastic disease, an area in which he has authored more than 60 publications on the biology, treatment, and long-term outcomes of the disease and is ranked among the top five GTN researchers worldwide.

Dr. Horowitz chairs the Gestational Trophoblastic Neoplasia Subcommittee for NRG Oncology and serves on the FIGO GTN Staging Committee and the international ESGO-EOTTD-ISSTD-GCIG guidelines working group for GTD management. In 2025, he was named the inaugural Ross S. Berkowitz, MD Chair in Gynecologic Oncology, and in 2024 he received the Brigham and Women’s Hospital Distinguished Clinician Award.

Please join us in welcoming Dr. Horowitz to our BIDMC and HMFP family.